Canada markets closed

Optimi Health Corp. (OPTI.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.3300+0.0050 (+1.54%)
At close: 03:24PM EDT
Full screen
Previous Close0.3250
Open0.3250
Bid0.3250 x N/A
Ask0.3300 x N/A
Day's Range0.3250 - 0.3350
52 Week Range0.1500 - 0.5800
Volume27,335
Avg. Volume72,617
Market Cap29.396M
Beta (5Y Monthly)1.37
PE Ratio (TTM)N/A
EPS (TTM)-0.0600
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    Optimi Health and Kwantlen Polytechnic University Applied Genomics Centre Partner to Advance Mushroom Science and Research

    VANCOUVER, British Columbia, April 23, 2024 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a leading Health Canada licensed psychedelics pharmaceutical manufacturer, is thrilled to announce an innovative research and development partnership with the Kwantlen Polytechnic University Applied Genomics Centre (KPU-AGC). The project, entitled, “Genetic Identification of Psilocybin Containing Mushroom,” will utilize KPU-AGC’s state-of-the-art genomics technology to unrav

  • GlobeNewswire

    Optimi Health Achieves Milestone: Completes In-House Production of MDMA Active Pharmaceutical Ingredient (API)

    Three batches tested and validated by third-party laboratoryVANCOUVER, British Columbia, April 15, 2024 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a leading Health Canada licensed psychedelics pharmaceutical manufacturer, specializing in controlled substances such as natural psilocybin and MDMA, has announced the completion of three batches of its MDMA Active Pharmaceutical Ingredient (API) manufactured from raw materials under the Company’s Precursor Licence.

  • Market Exclusive

    Weekly Roundup on the Cannabis Sector & Psychedelic Sector

    Key Takeaways; Cannabis Sector Village Farms regained Nasdaq compliance; Weedmaps is facing a compliance issue. MariMed expanded Maryland presence with a $5.3 million acquisition. Tilray adjusted expectations for 2024 amid financial challenges, as they eye Canadian tax relief. Key Takeaways; Psychedelic Sector Optimi Health partnered with a New Zealand institute to supply psilocybin for indigenous […]